Bullboard - Stock Discussion Forum Oncolytics Biotech Inc ONCY

Primary Symbol: T.ONC

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune... see more

Add To Watchlist

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Irinotecan

View:

Post by pelaboost on Feb 14, 2024 4:21pm

Irinotecan

Go back even further. You will find irinotecan and reovirus in 2014.

Thanks to dude for that post on twits. Very interesting.

157

Comment

Comment by askretka on Feb 15, 2024 4:25pm

Heineman remarked in the last quarterly that when PanCan gave us the 5 million for the FOLFIRINOX / Pelareorep trial that Pelareorep had been used before with some of the components that make up the FOLFIRINOX combo drug, namely Irinotecan as I read it. The fact that the latest first line FDA approval on the 13 of February 2024 for NALIRIFOX is the same as FOLFIRINOX pretty much except with a new ...more

240

Comment

Comment by bigkagan on Feb 15, 2024 9:30pm

Why can't ONC let its virus mutate in hopes that it will become stronger and could kill cancer on its own. If Covid mutates why can't pelareorep mutate also

119

Comment